Clinical trials: Peripheral Arterial Obstructive Disease
Peripheral Artery Disease
Predicting Outcomes of PAD Patients Undergoing Endovascular Intervention With CTA
Lower extremity peripheral artery disease (PAD), the third leading cause of atherosclerotic cardiovascular morbidity following coronary artery disease and stroke, affect 200 million people worldwide and is associated with high…
- Trial name
- NCT03974880
- Where
- China
- Volunteers
- 480 people
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
Peripheral Arterial Disease
Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP and Prox BTK-Lesions (JETART)
To demonstrate the efficacy and safety of the mechanical thrombectomy device (JETi 6F and 8F) for treatment of patients with symptomatic peripheral artery disease (PAD) due to acute or acute on chronic occlusions of the femoral…
- Trial name
- JETART (NCT06434779)
- Testing
- JETi 6F and 8F Thrombectomy system
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Vascular Science LP GmbH
Peripheral Arterial Disease, Type II Diabetes Mellitus
Dietary Nitrate and Exercise to Augment Exercise Training Benefits in Subjects With DM+PAD
The hypothesis of this proposal is that in subjects with Type II diabetes mellitus (T2D) and peripheral arterial disease (PAD) with intermittent claudication (IC), regular consumption of a high nitrate supplement which raises…
- Trial name
- DM+PAD (NCT01785524)
- Testing
- Beetroot Juice (Beet-It Stamina Shot) and Exercise Training
- Where
- United States
- Volunteers
- 18 people
- Sponsor
- Duke University
Peripheral Artery Disease, PAD
Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial
The GIFT pilot study will investigate the optimal subcutaneous dose and safety of subcutaneously administered unacylated ghrelin in older people with peripheral artery disease (PAD).
- Conditions
- Peripheral Artery Disease, PAD, Peripheral Arterial Disease
- Trial name
- GIFT (NCT03358355)
- Testing
- unacelyated ghrelin
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- Northwestern University
Intermittent Claudication, Peripheral Arterial Disease
SUPER Study; SUPERvised Exercise or Angioplasty for Intermittent Claudication Due to an Iliac Artery Obstruction.
The purpose of our study is to compare the clinical effectiveness and cost-effectiveness of two treatment strategies of Intermittent Claudication (IC) due to an iliac artery obstruction: to start with SUPERvised Exercise Therapy…
- Trial name
- SUPER (NCT01385774)
- Testing
- Percutaneous Transluminal Angioplasty, Supervised Exercise Therapy
- Where
- 15 sites in Netherlands
- Volunteers
- 240 people
- Sponsor
- M.J.W. Koelemaij
Peripheral Arterial Disease
Revascularization of Total or Sub-total Occluded Peripheral Arteries With ByCross® Device. Post Market Clinical Followup
Post market clinical follow up of Bycross® device.
- Trial name
- NCT05110079
- Testing
- ByCross Atherectomy and Thrombectomy
- Where
- 3 sites in Germany
- Volunteers
- 75 people
- Sponsor
- Taryag Medical Ltd.
Peripheral Arterial Disease
Ultrasonic Perfusion Estimation in Calf Muscle
The purpose of this study is to evaluate the potential of ultrasound perfusion imaging technique for assessing the progression of peripheral arterial disease (PAD) and monitoring its response to therapy by measuring changes in…
- Trial name
- NCT04755335
- Testing
- Ultrasound
- Where
- United States
- Volunteers
- 87 people
- Sponsor
- Mayo Clinic
Sarcopenia, Exercise Intolerance
Prehabilitation for Cardiac Surgery in Patients With Reduced Exercise Tolerance
Among patients awaiting cardiac surgery, a significant proportion are patients with severe angina, heart failure (HF) and peripheral atherosclerosis.
- Conditions
- Sarcopenia, Exercise Intolerance, Heart Failure, Peripheral Artery Disease
- Trial name
- NCT04545268
- Testing
- Neuromuscular electrical stimulation (NMES), Transcutaneous electrical stimulation
- Where
- Russia
- Volunteers
- 60 people
- Sponsor
- Research Institute for Complex Problems of Cardiovascular Diseases, Russia
Abdominal Aortic Aneurysms, Peripheral Arterial Disease
Randomized Preventive Vascular Screening Trial of 65-74 Year Old Men in the Central Region of Denmark
Well-documented health benefits may be achieved through prophylactic screening for cardiovascular disease. The advantages are fewer premature deaths and a reduction in the number of hospital admissions and amputations.
- Conditions
- Abdominal Aortic Aneurysms, Peripheral Arterial Disease, Hypertension
- Trial name
- NCT00662480
- Testing
- Screening for hypertension, lower limb atherosclerosis and abdominal aortic aneurysm
- Where
- Denmark
- Volunteers
- 40,000 people
- Sponsor
- Central Jutland Regional Hospital
Peripheral Arterial Disease
Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty
The main aim of the present study was to evaluate the therapeutic potential and safety of transarterial infusion of granulocyte colony stimulating factor (G-CSF) mobilized cluster of differentiation (CD) 133(+) cells when…
- Trial name
- NCT02915796
- Testing
- G-CSF + CD133(+) cells, G-CSF, percutaneous transluminal angioplasty (PTA)
- Where
- China
- Volunteers
- 345 people
- Sponsor
- Shanghai 10th People's Hospital
Abdominal Aortic Aneurysm, Coronary Artery Disease
White Blood Cell Counts and Onset of Cardiovascular Diseases: a CALIBER Study
The complete blood count is a commonly performed blood test, and previous small studies have suggested that the counts of some types of white blood cell in the complete blood count may be related to the onset of cardiovascular…
- Conditions
- Abdominal Aortic Aneurysm, Coronary Artery Disease, Stroke, Heart Failure
- Trial name
- CALIBER (NCT02014610)
- Volunteers
- 800,000 people, healthy volunteers welcome
- Sponsor
- University College, London
Peripheral Arterial Disease
Angiosome Perfusion After Tibial Bypass
Microcirculation should be assessed before and after tibial bypass surgery by intraoperative fluorescence angiography. According to this, the direct and the indirect angiosomes should be compared according to the individual…
- Trial name
- NCT03012750
- Testing
- Indocyanine Green
- Volunteers
- 40 people
- Sponsor
- University Hospital Erlangen
Peripheral Arterial Disease
Cost-utility Analysis of the Outpatient Versus Conventional Hospitalization in Treatment of Occlusive Arterial Disease
The purpose of this study is to assess the efficiency of outpatient surgery compared to conventional hospitalization in endovascular treatment of occlusive arterial disease.
- Trial name
- AMBUVASC (NCT02581150)
- Testing
- Treatment of Occlusive Arterial Disease
- Where
- 11 sites in France
- Volunteers
- 160 people
- Sponsor
- Nantes University Hospital
Peripheral Arterial Disease
Multifactor Risk Reduction for Optimal Management of PAD
Patients with peripheral arterial disease (PAD) experience significant functional limitations due to ischemic symptoms (claudication) and are at high risk for CVD morbidity and mortality resulting from untreated cardiovascular…
- Trial name
- VIGOR2 (NCT00537225)
- Testing
- exercise
- Volunteers
- 300 people
- Sponsor
- Palo Alto Veterans Institute for Research
Peripheral Arterial Disease
Granulocyte-Macrophage Stimulating Factor in the Treatment of Peripheral Arterial Disease
Peripheral arterial disease is a common condition in older adults involving poor arterial circulation in the legs leading to leg pain and debility.
- Trial name
- GPAD-2 (NCT01041417)
- Testing
- Granulocyte-Macrophage Stimulating Factor (GM-CSF)
- Where
- United States
- Volunteers
- 159 people
- Sponsor
- Emory University
Peripheral Arterial Occlusive Disease
Efficacy of Sildenafil on the Morbi-mortality of Peripheral Arterial Diseased Patients With Intermittent Claudication
Peripheral Arterial Disease (PAD) is a highly debilitating disease that affects 202 million people around the world and about 7 million people in France. Morbi-mortality from cardiovascular events is increased in this population.
- Trial name
- VALSTAR (NCT02930811)
- Testing
- Sildenafil 100 mg oral morning dose
- Sponsor
- University Hospital, Angers
Peripheral Arterial Disease
Ticagrelor and Peripheral Arterial Disease
This is an interventional study assessing the effectiveness of Ticagrelor on the reduction of thrombus burden using optical coherence tomography in patients undergoing peripheral artery stenting.
- Trial name
- NCT02407314
- Testing
- Percutaneous Peripheral Intervention, Optical Coherence Tomography, Ankle Brachial Index
- Where
- United States
- Volunteers
- 26 people
- Sponsor
- Arkansas Heart Hospital
Peripheral Artery Disease
Best Practice Advisory to Initiate High-Intensity Statin Therapy in Patients With Peripheral Artery Disease
The purpose of this study is to understand how a Best Practice Advisory (BPA) for high-intensity statin therapy in patients with Peripheral Artery Disease impacts prescription rates.
- Trial name
- NCT05166187
- Testing
- Best Practice Advisory
- Where
- United States
- Volunteers
- 152 people
- Sponsor
- Vanderbilt University Medical Center
Arterial Occlusive Diseases
YUKON-drug-eluting Stent Below The Knee - Randomised Double-blind Study
The purpose of this study is to compare the effectiveness of the treatment with balloon-expandable YUKON-BTX-Sirolimus-eluting stent over the treatment with YUKON-BTX uncoated stent in patients with ischemic infrapopliteal…
- Trial name
- YUKON-BTK (NCT00664963)
- Testing
- Implantation of YUKON Sirolimus-eluting Stent, Implantation of YUKON Stent (uncoated)
- Where
- 3 sites in Germany
- Volunteers
- 130 people
- Sponsor
- Herz-Zentrums Bad Krozingen
Peripheral Arterial Disease
EFFECT OF AEROBIC TRAINING VERSUS MYOFACIAL RELEASE ON CLAUDICATION AMONG PREPHERAIL ARTERAIL INSUFFIECENCY PATIENTS
This study is trying to answer the following research question: "Are there any differences between effects of aerobic training and myofascial release on claudication among peripheral arterial insuffiency patients?
- Trial name
- NCT04734600
- Testing
- Electronic Treadmill device, myofascial release technique
- Where
- Egypt
- Volunteers
- 40 people
- Sponsor
- ola mohamed elsayed mostafa elgohary
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.